NFKB1 and ovarian carcinoma: Intriguingly, a dominant-negative variant of PKCα inhibited LPA-induced NF-κB activation in this system, suggesting that this PKC isoform might have a role in upstream regulation of the CARMA3-containing CBM complex in ovarian cancer cells.